| Catalog Number |
AB9U14100090 |
| Medical Device Problem Code |
Detachment of Device or Device Component (2907)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/07/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that an attempt was made to use a ab9u14100090 abre stent to treat a soft tissue lesion in the proximal mid distal right and left common iliac vein (civ), external iliac vein (eiv).Degree of tortuosity was minimal.Degree of calcification was minimal.Stenosis 79% right iliac and 82% left iliac.Artery/vein diameter was 113mm2 left iliac and 123mm2 right iliac.High grade nonthrombotic iliac vein lesions (nivl) compressions bilaterally.Both right around 80%.9f terumo pinnacle sheaths were used bilaterally,.035 x 260cm boston scientific amplatz superstiff guidewires were used bilaterally.Vessel was pre-dilated.14x40 bard atlas balloons were used bilaterally for pre-dilation and post-dilation.Stent was mal-positioned between inner shaft and retractable sheath.Device unboxed, unpacked, and flushed without incident.While positioning stent system in the patient under fluoroscopy, physician noticed considerable distance between the radiopaque marker on the retractable sheath and the leading edge of the stent itself.Out of an abundance of caution, decision was made to remove the fully intact stent system from the patient and proceed with another abre stent of similar size.Device was safely removed from patient.Ab9u14120090 stent used to complete procedure.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Image analysis it is not possible to tell from the images provided if there was considerable distance between the radiopaque marker on the retractable sheath and the leading edge of the stent itself.Product analysis an abre device was returned for evaluation.The red locking pin was secure in the handle the size indicated on the strain relef is 9f 14mm x 100mm there was no issue noted between with the distance between the radiopaque marker on the retractable sheath and the leading edge of the stent itself medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|